Team (TISI) Q2 2026 Earnings Call Transcript

Team, Inc. (NYSE:TISI) reported Q2 revenue of $228.7M (-7.8% Y/Y) and a net loss of $6.8M (vs. -$4.3M in Q2 2025), with Adjusted EBITDA falling to $12.8M (5.6% margin) from $24.5M. The decline was driven by a ~51% YTD deferral of turnaround/maintenance as refinery customers extended runs amid favorable crack spreads, and Middle East conflict reduced H1 regional revenue by ~$20M. Management reaffirmed FY26 revenue guidance of $920M–$945M and Adjusted EBITDA of $68M–$73M (+~16% at the midpoint), but warned results are likely in the lower half of ranges due to timing uncertainty on returning deferred work tied to Middle East conditions; liquidity ended at $51.2M and net debt was $300.3M.

Analysis

Team is less a clean turnaround than a timing bet on refinery maintenance normalization. High crack spreads have rationally pushed customers to keep units running, so the near-term P&L is hostage to refining economics rather than internal execution; management can tighten costs, but it cannot force the deferred work back onto the calendar. That makes the equity behave like a levered call option on crack-spread compression, with fixed-cost deleverage still the dominant driver until activity actually returns.

Second-order, refiners such as VLO, MPC, and PSX are the near-term winners because they are monetizing uptime today, but they are also building a larger outage backlog that should eventually benefit TISI. If that backlog starts clearing in 2H26, the revenue inflection could be sharper than expected, but margin recovery may lag because catch-up work is usually lower quality and labor utilization takes time to normalize. The diversification push into LNG, aerospace, and nuclear is directionally right, yet those markets are unlikely to offset refining cyclicality over the next 1-2 quarters.

The contrarian miss is that the larger Stellex stake may reflect capital-structure optionality more than operational confidence. With limited liquidity and elevated leverage, another soft quarter would shift the story from cyclical recovery to balance-sheet defense. The main falsifier is crack spreads staying elevated into year-end or renewed Middle East disruption keeping maintenance deferred; conversely, crack compression plus visible backlog conversion would create meaningful upside because the stock is still priced like a stressed turnaround rather than a normalized industrial.

Key Decisions for Investors

• No outright long TISI yet; wait for Q3 evidence that deferred maintenance is converting into booked work and backlog growth. If that does not show by the next print, the recovery thesis is not working.
• Tactical pair trade for 1-3 months: long VLO or PSX vs short TISI while crack spreads remain elevated and turnaround deferrals persist. Cover the short if cracks compress materially or TISI shows a real bookings inflection.
• Treat TISI as a balance-sheet-sensitive cyclical, not a quality compounder; set a downside alert if liquidity trends lower or EBITDA guidance is cut again. That would increase dilution risk and justify de-risking immediately.
• Watch MG as a cleaner rebound vehicle for maintenance/inspection normalization if you want exposure to the same end-market inflection with less capital-structure risk.